NCT01012362 arm group d1f5f83d78191ae623187b16cac7627e [clinicaltrials_resource:NCT01012362/arm-group/d1f5f83d78191ae623187b16cac7627e]
arm group [clinicaltrials_vocabulary:arm-group]
NCT01012362 arm group d1f5f83d78191ae623187b16cac7627e [clinicaltrials_resource:NCT01012362/arm-group/d1f5f83d78191ae623187b16cac7627e]
Bio2RDF identifier
NCT01012362/arm-group/d1f5f83d78191ae623187b16cac7627e
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... f5f83d78191ae623187b16cac7627e
description [clinicaltrials_vocabulary:description]
Patient receives assigned dose ...... anib and ixabepilone 32 mg/m2.
identifier
clinicaltrials_resource:NCT01012362/arm-group/d1f5f83d78191ae623187b16cac7627e
title
NCT01012362 arm group d1f5f83d78191ae623187b16cac7627e
@en
type
label
NCT01012362 arm group d1f5f83d ...... 5f83d78191ae623187b16cac7627e]
@en